Compare ARM & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARM | ELV |
|---|---|---|
| Founded | 1990 | 1944 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.3B | 76.5B |
| IPO Year | 2023 | 2001 |
| Metric | ARM | ELV |
|---|---|---|
| Price | $124.10 | $292.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 18 |
| Target Price | $160.63 | ★ $386.59 |
| AVG Volume (30 Days) | ★ 5.5M | 1.6M |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 25.21 |
| Revenue | N/A | ★ $199,125,000,000.00 |
| Revenue This Year | $23.68 | N/A |
| Revenue Next Year | $20.58 | $3.10 |
| P/E Ratio | $169.67 | ★ $11.36 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $80.00 | $273.71 |
| 52 Week High | $183.16 | $458.75 |
| Indicator | ARM | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 53.15 | 31.05 |
| Support Level | $101.02 | $274.06 |
| Resistance Level | $135.21 | $322.45 |
| Average True Range (ATR) | 5.37 | 11.79 |
| MACD | -0.41 | -4.98 |
| Stochastic Oscillator | 44.96 | 13.75 |
Arm Holdings is the IP owner and developer of the ARM architecture, which is used in 99% of the world's smartphone CPU cores, and it also has high market share in other battery-powered devices like wearables, tablets, or sensors. Arm licenses its architecture for a fee, offering different types of licenses depending on the flexibility the customer needs. Customers like Apple or Qualcomm buy architectural licenses, which allow them to modify the architecture and add or delete instructions to tailor the chips to their specific needs. Other clients directly buy off-the-shelf designs from Arm. Both off-the-shelf and architectural customers pay a royalty fee per chip shipped.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.